Article Details

Trefoil Therapeutics banks $28M to create first drug for genetic eye disorder

Retrieved on: 2019-07-15 19:26:15

Tags for this article:

Click the tags to see associated articles and topics

Trefoil Therapeutics banks $28M to create first drug for genetic eye disorder. View article details on hiswai:

Excerpt

<div>Bios Partners led the financing, with Access Biotechnology, Aju IB Investment, <b>Correlation Ventures</b>, ExSight Ventures, Hatteras Venture Partners and ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up